TP53 and Alzheimer disease: Even though the reporter assay was designed for testing participation of p53 in mitochondrial genome transcription via mito‐p53 BEs, mito‐p53 BE‐driven reporter activity did not exactly correlate with net levels of mitochondrial gene expression in cell lines and human AD brains.